Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹20,374Cr
Chemicals - Inorganic - Caustic Soda/Soda Ash
Rev Gr TTM
Revenue Growth TTM
-1.33%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TATACHEM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 26.6 | 5.6 | -5.7 | -10.1 | -21.1 | -10.2 | 0.0 | -3.8 | 1.0 | -1.9 | -3.0 | -1.1 |
| 3,442 | 3,175 | 3,179 | 3,188 | 3,032 | 3,215 | 3,381 | 3,156 | 3,182 | 3,070 | 3,340 | 3,205 |
Operating Profit Operating ProfitCr |
| 21.9 | 24.7 | 20.5 | 14.5 | 12.8 | 15.2 | 15.4 | 12.1 | 9.3 | 17.4 | 13.8 | 9.7 |
Other Income Other IncomeCr | 88 | 58 | 175 | 98 | -838 | 101 | 152 | -10 | 11 | 138 | 128 | 21 |
Interest Expense Interest ExpenseCr | 133 | 123 | 145 | 132 | 130 | 133 | 145 | 148 | 137 | 147 | 144 | 146 |
Depreciation DepreciationCr | 234 | 229 | 234 | 246 | 271 | 273 | 277 | 280 | 293 | 280 | 285 | 293 |
| 686 | 749 | 615 | 262 | -796 | 269 | 348 | -4 | -92 | 360 | 236 | -73 |
| -8 | 171 | 120 | 68 | 22 | 94 | 81 | 17 | -25 | 44 | 82 | -4 |
|
Growth YoY PAT Growth YoY% | 55.5 | -7.8 | -27.2 | -54.4 | -221.5 | -67.6 | -46.1 | -110.8 | 94.2 | 66.3 | -42.3 | -228.6 |
| 15.7 | 13.9 | 12.4 | 5.2 | -24.2 | 5.0 | 6.7 | -0.6 | -1.4 | 8.5 | 4.0 | -1.9 |
| 27.8 | 20.9 | 16.8 | 6.2 | -33.4 | 5.9 | 7.6 | -2.1 | -2.2 | 9.9 | 3.0 | -3.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -13.6 | -30.4 | -0.7 | 0.7 | 0.2 | -1.5 | 23.8 | 33.0 | -8.2 | -3.5 | -1.6 |
| 15,040 | 12,781 | 8,252 | 8,079 | 8,556 | 8,408 | 8,699 | 10,317 | 12,967 | 12,574 | 12,934 | 12,797 |
Operating Profit Operating ProfitCr |
| 12.6 | 14.1 | 20.2 | 21.3 | 17.2 | 18.8 | 14.7 | 18.3 | 22.8 | 18.5 | 13.1 | 12.7 |
Other Income Other IncomeCr | -82 | 140 | 182 | 273 | 579 | 307 | 260 | 471 | 216 | -507 | 254 | 298 |
Interest Expense Interest ExpenseCr | 461 | 525 | 297 | 326 | 354 | 342 | 367 | 303 | 406 | 530 | 563 | 574 |
Depreciation DepreciationCr | 463 | 526 | 512 | 518 | 569 | 666 | 759 | 806 | 892 | 980 | 1,123 | 1,151 |
| 1,159 | 1,180 | 1,467 | 1,620 | 1,437 | 1,248 | 634 | 1,667 | 2,740 | 830 | 521 | 431 |
| 351 | 248 | 346 | 60 | 274 | 220 | 198 | 267 | 288 | 381 | 167 | 97 |
|
| | 15.4 | 20.3 | 39.2 | -25.5 | -11.6 | -57.6 | 220.9 | 75.1 | -81.7 | -21.2 | -0.6 |
| 4.7 | 6.3 | 10.8 | 15.2 | 11.3 | 9.9 | 4.3 | 11.1 | 14.6 | 2.9 | 2.4 | 2.4 |
| 10.2 | 13.2 | 17.0 | 41.5 | 19.7 | 275.0 | 10.1 | 49.4 | 91.0 | 10.5 | 9.2 | 7.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 |
| 5,297 | 6,600 | 7,653 | 10,847 | 12,086 | 12,643 | 14,035 | 17,998 | 19,466 | 21,986 | 21,339 | 22,103 |
Current Liabilities Current LiabilitiesCr | 6,902 | 5,025 | 5,606 | 3,703 | 3,949 | 7,025 | 4,463 | 7,096 | 4,904 | 6,055 | 6,139 | 4,886 |
Non Current Liabilities Non Current LiabilitiesCr | 7,696 | 9,877 | 7,473 | 8,356 | 7,700 | 7,002 | 8,731 | 7,590 | 9,538 | 7,587 | 9,140 | 10,638 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 8,174 | 7,579 | 7,374 | 9,040 | 8,098 | 7,799 | 6,646 | 8,745 | 8,164 | 6,367 | 6,720 | 6,655 |
Non Current Assets Non Current AssetsCr | 12,649 | 16,777 | 16,236 | 16,839 | 18,807 | 19,890 | 21,691 | 25,098 | 26,920 | 30,389 | 31,060 | 32,200 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1,274 | 2,332 | 3,531 | 1,870 | 1,581 | 1,780 | 2,037 | 1,645 | 2,971 | 3,016 | 1,761 |
Investing Cash Flow Investing Cash FlowCr | -655 | -489 | -982 | 2,707 | -1,958 | -2,368 | -1,130 | -836 | -1,186 | -610 | -1,681 |
Financing Cash Flow Financing Cash FlowCr | -1,087 | -1,802 | -2,341 | -2,089 | -1,712 | -129 | -1,456 | -755 | -2,076 | -2,494 | 29 |
|
Free Cash Flow Free Cash FlowCr | 709 | 1,645 | 2,888 | 1,140 | 502 | 611 | 804 | 380 | 1,427 | 1,193 | -191 |
| 157.7 | 250.2 | 315.1 | 119.9 | 136.0 | 173.1 | 467.0 | 117.5 | 121.2 | 671.7 | 497.5 |
CFO To EBITDA CFO To EBITDA% | 58.8 | 111.5 | 168.6 | 85.4 | 88.8 | 91.3 | 135.8 | 71.4 | 77.7 | 105.9 | 90.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 11,260 | 9,509 | 15,256 | 17,241 | 14,967 | 5,681 | 19,139 | 24,826 | 24,768 | 27,529 | 22,039 |
Price To Earnings Price To Earnings | 21.5 | 12.3 | 15.4 | 7.1 | 12.9 | 0.8 | 74.7 | 19.8 | 10.7 | 102.8 | 93.8 |
Price To Sales Price To Sales | 0.7 | 0.6 | 1.5 | 1.6 | 1.4 | 0.5 | 1.8 | 1.9 | 1.4 | 1.8 | 1.4 |
Price To Book Price To Book | 2.0 | 1.4 | 1.9 | 1.6 | 1.2 | 0.4 | 1.3 | 1.4 | 1.3 | 1.2 | 1.0 |
| 7.8 | 8.0 | 8.9 | 8.3 | 10.2 | 4.7 | 16.4 | 13.3 | 8.0 | 11.4 | 14.6 |
Profitability Ratios Profitability Ratios |
| 59.5 | 60.0 | 80.0 | 82.9 | 80.6 | 81.0 | 76.5 | 79.1 | 80.5 | 82.5 | 80.7 |
| 12.6 | 14.1 | 20.2 | 21.3 | 17.2 | 18.8 | 14.7 | 18.3 | 22.8 | 18.5 | 13.1 |
| 4.7 | 6.3 | 10.8 | 15.2 | 11.3 | 9.9 | 4.3 | 11.1 | 14.6 | 2.9 | 2.4 |
| 12.9 | 11.1 | 13.6 | 11.7 | 10.3 | 8.6 | 4.7 | 7.8 | 12.1 | 4.9 | 3.8 |
| 14.5 | 13.6 | 14.2 | 14.1 | 9.4 | 8.0 | 3.0 | 7.7 | 12.4 | 2.0 | 1.6 |
| 3.9 | 3.8 | 4.8 | 6.0 | 4.3 | 3.7 | 1.5 | 4.1 | 7.0 | 1.2 | 0.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Tata Chemicals Limited (TCL), a part of the $150 billion Tata Group, is a leading global provider of chemistry-based solutions with a diversified portfolio across **Basic Chemistry Products** and **Specialty Products**. The company operates 15 manufacturing facilities across **India, the USA, the UK, and Kenya**, serving over **95 countries** globally. With a strategic focus on **sustainability, innovation, and digital transformation**, TCL is positioned as a leader in key inorganic and specialty chemicals, while advancing its footprint in green chemistry, nutrition, and agriculture.
---
### **Business Segments**
TCL operates through two distinct segments:
#### 1. **Basic Chemistry Products**
- A global leader in inorganic chemicals, ranked **3rd in soda ash** and **5th in sodium bicarbonate** production.
- Key products:
- **Soda Ash**: Light (detergents, silicates) and Dense (glass, containers)
- **Sodium Bicarbonate**: Industrial, food, pharmaceutical, and flue gas applications
- **Salt**: Edible, industrial, de-icing, and high-grade pharma salt
- **Cement**: OPC, PPC, Masonry Cement (utilizing waste from soda ash production)
- **Production Spread Across Four Continents**:
- **India**: Major hub at Mithapur, Gujarat
- **USA (Wyoming)**: Natural soda ash from trona mining
- **UK (Winnington, Middlewich)**: Synthetic chemicals and pharma-grade salts
- **Kenya (Magadi)**: Natural soda ash and salt
- **Capacity Highlights (Nov 2025)**:
- Soda Ash: **1.44 million MTPA** (India: 1.091M, Kenya: 0.35M)
- Sodium Bicarbonate: **380,000 MTPA** (India: 290K, UK: 90K)
- Salt: **1.6 million MTPA** in India, plus **430,000 MTPA** in the UK
- Pharma-Grade Salt: **70,000 MTPA** in UK; expansion underway in India
- Cement: 500,000 MTPA
> *Note: Following the closure of UK soda ash operations (May 2025), TCL now serves European markets via U.S.-sourced soda ash and is pivoting toward high-margin products like pharma-grade salt and premium bicarbonate.*
---
#### 2. **Specialty Products**
Innovation-driven segment focused on sustainable, high-value chemistry solutions.
##### **a. Specialty Silica (Cuddalore, Tamil Nadu & Andhra Pradesh)**
- **Highly Dispersible Silica (HDS)** for green tyres in passenger and truck/bus radial (PCR/TBR) applications.
- **Green Silica** sourced from **Rice Husk Ash (RHA)**—a low-carbon alternative supporting EV and fuel-efficient tyre trends.
- **Commercial Grades**:
- **TREADSIL™**, **TYSIL™**, **TAVERSIL™** for tyres, silicone rubber, food, oral care, agrochemicals
- **TAVERSIL™ 115**, **120F**, **150** for battery separators, paints, and defoamers
- **Capacity**:
- **10,800 MTPA**, with 95% utilisation (HDS line)
- **Module-based expansion** of 60,000 tons underway in three 20,000-ton phases (first line in 24 months)
- **Global Presence**: Supplying major Indian and international tyre brands; approvals secured with domestic tyre OEMs.
##### **b. Prebiotics & Nutrition (Mambattu, Andhra Pradesh)**
- Flagship brand: **FOSSENCE®** (Fructo-Oligosaccharides), a short-chain prebiotic promoting gut health.
- **Applications**:
- Food & Beverage: Sugar/fat replacers in gummies, cakes, biscuits, Indian sweets
- Nutraceuticals & Infant Nutrition
- Animal & **Pet Nutrition**: Strong traction in USA, Southeast Asia, EU
- **FOS Production & Growth**:
- FY2024–25: **2,922 MT sold**, with **74% YoY growth**
- Fulfilled 3,000 MT of FOS contracts; Mambattu plant qualified by global clients
- **Innovations**:
- FOS L95 trials successful in gummies, cakes, and biscuits
- Sugar-replacement formulation with 1:1 taste/texture match
- Fat replacer blends for healthier bakery products
- Microbial encapsulation for improved mineral stability
- **Global Expansion**: Distributors in USA, Europe; sales in Australia, Thailand, Vietnam, South Korea
##### **c. Agri Inputs (via Rallis India Limited)**
- **Rallis India**, a publicly listed subsidiary, is a leader in the Indian agri-input space with presence in:
- **Crop Protection**: Herbicides, insecticides, fungicides (e.g., Acephate, Hexaconazole)
- **Biologicals & Bio-Pesticides**: Ralli Bactilis, Flavocide®
- **Nutrition**: Water-soluble, bio-fertilizers, micronutrients (e.g., AQUAFERT®)
- **Seeds**: Hybrids in cotton, maize, paddy, millet, mustard, vegetables
- **Distribution**:
- Reaches **80% of Indian districts** via 7,200+ dealers and 100,000 retailers
- Exports to **70+ countries**, including formulation supply and Custom Synthesis (CSM)
- **Digital Farming Initiatives**:
- **DRISHTI**: AI + satellite-powered field monitoring
- **SeedSay**: Predictive demand analytics
- **Seedsure**: Real-time hybrid seed monitoring platform
- **Crop Care Launches (2025)**:
- Daksh Plus (herbicide), Zaafu (fungicide), RALLIZIN (Zn-rich fertilizer)
- New cotton hybrids: **Diggaz**, **Aatish** achieving commercial success
---
### **Sustainability & Green Chemistry**
Sustainability is central to TCL’s long-term strategy:
- **Electric Calcination** in Kenya (low-carbon, modular capacity expansion)
- **EcoKarb®**: Net-zero sodium bicarbonate from **Carbon Capture & Utilisation (CCU)**; used in dialysis and export markets
- **Bio-based Innovations**:
- FOS from renewable feedstock (sugar)
- Bio-surfactants (solvent-free, zero-waste process)
- Organosilane via green chemistry (no VOCs)
- **Renewables & Decarbonization**:
- Energy-from-waste plant to be commissioned at Lostock, UK (H2 FY25)
- Solar, wind, and biomass integration across sites
- **Circular Economy**:
- Utilizes waste from soda ash process for cement production
- Battery recycling and recycling of critical materials from spent EV batteries
---
### **Digital & Innovation Strategy**
TCL is investing in digital transformation and R&D to drive efficiency and innovation:
- **AI & Machine Learning**:
- Predictive maintenance via tri-axial vibration analysis
- AI-driven crop hybrid selection
- Real-time analytics for asset health monitoring
- **Centre of Excellence (CoE) for AI & Digital**:
- Launch planned in FY26; focused on scaling digital value
- **ChemConnect Platform**: Cloud-based B2B system with 99% channel order adoption, integrated finance, and logistics tracking
- **Innovation Centres**:
- Three R&D hubs: Pune (Material, Nutritional, Energy Sciences), Bengaluru (Agri R&D, Seed Tech)
- 200+ scientists; **185 patents held**, 114 active patent applications
- Innovations:
- Inulin from dried chicory (patented)
- MicroSphere Silica (non-fluffy, pearl-form)
- Enzymatic FOS with customizable chain lengths
---
### **Global Expansion & Market Development**
- **Geographic Reach**: 95 countries; revenue mix (2024):
- **Asia (45%)** | **Americas (35%)** | **Europe (16%)** | **Africa (5%)**
- **Sales Growth Initiatives**:
- Appointed distributors in **USA, Europe**
- Gained access to **Chinese market** post-customs registration
- Secured customers in baby food, cakes, gummies sectors
- Expanding L95 and L55 prebiotics in **Australia, EU, Thailand**
- **Strategic Exports**:
- Direct export capability post-**exit from ANSAC** (2023)
- Building in-house global sales & supply chain teams
- Focus on pharma-grade bicarbonate and salt
---
### **Strategic Priorities (FY25 Forward)**
1. **Strengthen Core Leadership**: Expand soda ash, salt, and bicarb capacities in India, USA, and Kenya.
2. **Drive Specialty Growth**: Invest in HDS, RHA-based silica, FOS expansion, and agri-science innovation.
3. **Enhance Sustainability**: Increase renewable energy use, scale low-carbon products (EcoKarb®, RHA silica).
4. **Digital Transformation**: Deploy AI, data analytics, and automation across manufacturing and supply chain.
5. **Financial Discipline**: Generate cash, reduce leverage, and maintain cost efficiency amidst global volatility.